RdRP-IN-3

• UNSPSC Description:

  RdRP-IN-3 is a promising anti-influenza agent candidate by inhibiting the activity of RNA-dependent RNA polymerase (RdRp).

• Target Antigen:

  DNA/RNA Synthesis; Influenza Virus

• Type:

  Reference compound

• Related Pathways:

  Anti-infection;Cell Cycle/DNA Damage

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/rdrp-in-3.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1N2[C@](COCC2)([H])N(C3C4=CC=CC=C4C=CC5=CC=CC=C35)N6C1=C(O)C(C=C6)=O

• Molecular Weight:

  427.45

• References & Citations:

  [1]Tang L, et al. Synthesis and Anti-Influenza Virus Effects of Novel Substituted Polycyclic Pyridone Derivatives Modified from Baloxavir. J Med Chem. 2021 Oct 14;64(19):14465-14476.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2641299-75-2